USD 1.18
(-8.01%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 4.24 Million USD | -67.39% |
2022 | 13.01 Million USD | 3.31% |
2021 | 12.59 Million USD | 255.82% |
2020 | 3.54 Million USD | -36.68% |
2019 | 5.59 Million USD | 0.0% |
2018 | - USD | 0.0% |
2017 | - USD | -100.0% |
2016 | 7.9 Million USD | 9.33% |
2015 | 7.23 Million USD | -73.36% |
2014 | 27.15 Million USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
2011 | - USD | 0.0% |
2010 | - USD | 0.0% |
2009 | - USD | 0.0% |
2008 | - USD | 0.0% |
2007 | - USD | 0.0% |
2006 | - USD | 0.0% |
2005 | - USD | 0.0% |
2004 | - USD | 0.0% |
2003 | - USD | 0.0% |
2002 | - USD | 0.0% |
2001 | - USD | 0.0% |
2000 | - USD | 0.0% |
1999 | - USD | 0.0% |
1998 | - USD | 0.0% |
1997 | - USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | 1.34 Million USD | -68.35% |
2024 Q2 | 1.28 Million USD | -100.0% |
2023 FY | 4.24 Million USD | -67.39% |
2023 Q1 | 12.88 Million USD | -1.02% |
2023 Q3 | 13.12 Million USD | 1.3% |
2023 Q2 | 12.95 Million USD | 0.57% |
2023 Q4 | 4.24 Million USD | -67.66% |
2022 FY | 13.01 Million USD | 3.31% |
2022 Q2 | 12.97 Million USD | -2.19% |
2022 Q1 | 13.26 Million USD | 5.3% |
2022 Q3 | 10.17 Million USD | -21.59% |
2022 Q4 | 13.01 Million USD | 27.93% |
2021 Q4 | 12.59 Million USD | 290.33% |
2021 Q2 | 3.1 Million USD | -6.52% |
2021 Q3 | 3.22 Million USD | 3.8% |
2021 FY | 12.59 Million USD | 255.82% |
2021 Q1 | 3.32 Million USD | -6.05% |
2020 Q4 | 3.54 Million USD | -5.5% |
2020 Q3 | 3.74 Million USD | -48.96% |
2020 FY | 3.54 Million USD | -36.68% |
2020 Q1 | 2.58 Million USD | -53.78% |
2020 Q2 | 7.34 Million USD | 184.06% |
2019 Q2 | 1.73 Million USD | -8.48% |
2019 Q4 | 5.59 Million USD | -14.52% |
2019 Q1 | 1.89 Million USD | 0.0% |
2019 Q3 | 6.54 Million USD | 276.35% |
2019 FY | 5.59 Million USD | 0.0% |
2018 Q3 | - USD | 0.0% |
2018 FY | - USD | 0.0% |
2018 Q1 | - USD | 0.0% |
2018 Q2 | - USD | 0.0% |
2018 Q4 | - USD | 0.0% |
2017 FY | - USD | -100.0% |
2017 Q1 | 4.36 Million USD | -44.82% |
2017 Q3 | - USD | 0.0% |
2017 Q2 | - USD | -100.0% |
2017 Q4 | - USD | 0.0% |
2016 Q4 | 7.9 Million USD | 50.14% |
2016 FY | 7.9 Million USD | 9.33% |
2016 Q3 | 5.26 Million USD | 4.19% |
2016 Q2 | 5.05 Million USD | -17.63% |
2016 Q1 | 6.13 Million USD | -15.15% |
2015 Q2 | 27.69 Million USD | 1.26% |
2015 Q3 | 27.91 Million USD | 0.78% |
2015 Q4 | 7.23 Million USD | -74.09% |
2015 FY | 7.23 Million USD | -73.36% |
2015 Q1 | 27.34 Million USD | 0.72% |
2014 Q1 | - USD | 0.0% |
2014 Q4 | 27.15 Million USD | 0.0% |
2014 FY | 27.15 Million USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2013 Q2 | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2013 Q3 | - USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2012 FY | - USD | 0.0% |
2012 Q3 | - USD | 0.0% |
2012 Q2 | - USD | 0.0% |
2012 Q1 | - USD | 0.0% |
2011 Q4 | - USD | 0.0% |
2011 Q3 | - USD | 0.0% |
2011 Q1 | - USD | 0.0% |
2011 Q2 | - USD | 0.0% |
2011 FY | - USD | 0.0% |
2010 FY | - USD | 0.0% |
2010 Q4 | - USD | 0.0% |
2010 Q2 | - USD | 0.0% |
2010 Q3 | - USD | 0.0% |
2010 Q1 | - USD | 0.0% |
2009 Q1 | - USD | 0.0% |
2009 Q3 | - USD | 0.0% |
2009 Q4 | - USD | 0.0% |
2009 FY | - USD | 0.0% |
2009 Q2 | - USD | 0.0% |
2008 Q4 | - USD | 0.0% |
2008 Q2 | - USD | 0.0% |
2008 FY | - USD | 0.0% |
2008 Q1 | - USD | 0.0% |
2008 Q3 | - USD | 0.0% |
2007 Q1 | - USD | 0.0% |
2007 Q4 | - USD | 0.0% |
2007 Q3 | - USD | 0.0% |
2007 Q2 | - USD | 0.0% |
2007 FY | - USD | 0.0% |
2006 Q3 | - USD | 0.0% |
2006 FY | - USD | 0.0% |
2006 Q2 | - USD | 0.0% |
2006 Q4 | - USD | 0.0% |
2006 Q1 | - USD | 0.0% |
2005 FY | - USD | 0.0% |
2005 Q4 | - USD | 0.0% |
2005 Q3 | - USD | 0.0% |
2005 Q2 | - USD | 0.0% |
2005 Q1 | - USD | 0.0% |
2004 Q4 | - USD | 0.0% |
2004 Q3 | - USD | 0.0% |
2004 Q2 | - USD | 0.0% |
2004 Q1 | - USD | 0.0% |
2004 FY | - USD | 0.0% |
2003 Q4 | - USD | 0.0% |
2003 Q2 | - USD | 0.0% |
2003 FY | - USD | 0.0% |
2003 Q1 | - USD | 0.0% |
2003 Q3 | - USD | 0.0% |
2002 Q2 | - USD | 0.0% |
2002 Q1 | - USD | 0.0% |
2002 FY | - USD | 0.0% |
2002 Q4 | - USD | 0.0% |
2002 Q3 | - USD | 0.0% |
2001 Q2 | - USD | 0.0% |
2001 FY | - USD | 0.0% |
2001 Q4 | - USD | 0.0% |
2001 Q1 | - USD | 0.0% |
2001 Q3 | - USD | 0.0% |
2000 Q4 | - USD | 0.0% |
2000 FY | - USD | 0.0% |
2000 Q1 | - USD | 0.0% |
2000 Q2 | - USD | 0.0% |
2000 Q3 | - USD | 0.0% |
1999 Q4 | - USD | 0.0% |
1999 Q3 | - USD | 0.0% |
1999 FY | - USD | 0.0% |
1999 Q2 | - USD | 0.0% |
1999 Q1 | - USD | 0.0% |
1998 Q1 | - USD | 0.0% |
1998 Q3 | - USD | 0.0% |
1998 Q4 | - USD | 0.0% |
1998 Q2 | - USD | 0.0% |
1998 FY | - USD | 0.0% |
1997 FY | - USD | 0.0% |
1997 Q4 | - USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
American Bio Medica Corporation | 6000.00 USD | -70616.667% |
Arrayit Corporation | - USD | -Infinity% |
Atlantic International Corp. | 1.29 Million USD | -227.01% |
Biocept, Inc. | 10.37 Million USD | 59.104% |
Bioqual, Inc. | - USD | -Infinity% |
CardioGenics Holdings Inc | - USD | -Infinity% |
DermTech, Inc. | 51.3 Million USD | 91.73% |
Global WholeHealth Partners Corporation | - USD | -Infinity% |
Hangzhou Tigermed Consulting Co., Ltd. | 61.22 Million USD | 93.07% |
HTG Molecular Diagnostics, Inc. | 546.32 Thousand USD | -676.645% |
iMD Companies, Inc. | 1.1 Million USD | -284.446% |
IDenta Corp. | 428.17 Thousand USD | -890.948% |
Integrative Health Technologies, Inc. | - USD | -Infinity% |
InVitro International | - USD | -Infinity% |
Lumos Diagnostics Holdings Limited | - USD | -Infinity% |
Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
Medical Imaging Corp. | 278 Thousand USD | -1426.259% |
NovelStem International Corp. | 3.32 Million USD | -27.624% |
Optigenex Inc. | 4.42 Million USD | 4.158% |
PharmChem, Inc. | - USD | -Infinity% |
Proteome Sciences plc | 1.63 Million USD | -160.147% |
Response Genetics, Inc | 4.91 Million USD | 13.725% |
Rennova Health, Inc. | 359.19 Thousand USD | -1081.259% |
RushNet, Inc. | 4.25 Million USD | 0.221% |
ScreenPro Security Inc. | 249.05 Thousand USD | -1603.674% |
Stella Diagnostics Inc. | 798.44 Thousand USD | -431.411% |
StageZero Life Sciences Ltd. | 576.38 Thousand USD | -636.144% |
Todos Medical Ltd. | 33 Million USD | 87.143% |